Table 3.
Experimental data
| PS level |
14% |
14.39% |
16.52% |
20% |
30% |
|---|---|---|---|---|---|
| Experimental conditions | PSA-3 (genetic PS deficient) | HEK293 treated with 5 μM fendiline | HEK293 treated with 1 μM fendiline | HEK293 (WT) | PSA-3 supplied with additional PS |
| Oligomer ratio (24 h) | √ | √ | |||
| VLP production (24 h) | √ | ||||
| Relative oligomer frequency (24 h) | √ | √ | √ | ||
| Relative VLP production (24 h) | √ | √ | √ | ||
| Relative VLP production (48 h) | √ | √ | √ | √ | |
| VP40 budding ratio (48 h) | √ |